Mutations Associated with Carnitine Deficiency: Risk Factor for Regression in ASD
Mutations Associated with Carnitine Deficiency: Risk Factor for Regression in ASD
批准号:
8509954
负责人:
Robin P. Kochel
金额:
$7.87万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2015-07-31
关键词:
AffectAgeAnabolismAutistic DisorderBehaviorCarnitineChildChildhoodCognitiveCollectionDNA SequenceDataDevelopmentDiagnosisDiagnosticDietExonsFrequenciesGenesGeneticGenotypeGoalsInterviewLanguageLeadLifeLogistic RegressionsMethodsMutationNeuronsOutcomeParticipantResearch PersonnelRiskRisk FactorsSamplingautism spectrum disordercase controldesignexperienceinterestpreventprogramspublic health relevancerepositoryskillssocial skillsstatistics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This study will explore a possible etiological mechanism for regression among children with autism spectrum disorders (ASD). By definition, children with ASD present with aberrant development in social skills, language, and restricted or repetitive behaviors/interests within the first 3 years of life. However, the trajectory of ASD is ot uniform across affected children. Nearly one third of children with ASD experience developmental regression, or a loss of previously acquired skills, most often in language and social skills, between the ages of 1 and 3. While some regain the skills lost, those who regress have poorer cognitive and adaptive-functioning outcomes by age 8. No one knows what causes regression. In the search for an ASD etiological mechanism, researchers have noted significantly reduced levels of carnitine among those with ASD. Mutations in the genes TMLHE and SLC22A5 lead to neuronal and systemic carnitine deficiency, respectively. New data from the Beaudet lab suggest that mutations in (a) TMLHE are present in at least 1/200 ASD cases and (b) SLC22A exist in 1/35 ASD cases with regression. We believe that children with ASD who have TMLHE and SLC22A5 mutations could experience regression because of reduced capacity for carnitine biosynthesis. This study will use the matched case-control design to investigate whether TMLHE and SLC22A5 mutations are more common among children with ASD and regression (cases) than those without regression (controls). Specific aims are to (1) perform genotyping for the TMLHE and SLC22A5 genes on existing samples from children with ASD; (2) ascertain regression status for genotyped children; and (3) compare the frequencies of mutations in the TMLHE and SLC22A5 genes between cases and controls. We hypothesize that children with ASD and regression will have greater odds of having mutations in TMLHE and SLC22A5 than those with ASD who have not regressed. Participants will be 1200 children from the Simons Simplex Collection, a repository of genetic and phenotypic data from children with ASD. Regression data will be ascertained from the skill-loss items of the Autism Diagnostic Interview-Revised. Genotyping involves sequencing all exons and determining copy number for exons in both genes. Frequencies of mutations for TMLHE and SLC22A5 will be compared between groups (regressed vs. nonregressed) using conditional logistic regression statistics. Findings could lead to methods for predicting and preventing regression among children with ASD through dietary programs, subsequently enhancing their cognitive and adaptive-functioning outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Paternal Brain Responses to Infant Face Cues: Effects of Intranasal Oxytocin
-
批准号:8899978
-
项目类别:
-
资助金额:$7.05万
-
财政年份:2015
-
负责人:Robin P. Kochel
-
依托单位:
Paternal Brain Responses to Infant Face Cues: Effects of Intranasal Oxytocin
-
批准号:9043152
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2015
-
负责人:Robin P. Kochel
-
依托单位:
SIMONS SIMPLEX COLLECTION
-
批准号:8356697
-
项目类别:
-
资助金额:$14.48万
-
财政年份:2010
-
负责人:Robin P. Kochel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: